Subtle Pharmaceuticals Private Limited, a active private limited company, was established on 26 September 2020 in Bangalore North, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304KA2020PTC139065. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Menaka Thangaraj (Director), Ujjani Shivananjappa Sunil Kumar (Director). It holds ₹9.14 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, A 419 And A 420,, 9 And 10Th Main Road, 2Nd Stage, Peenya Industrial Area, Bangalore North, Karnataka, 560058.
U24304KA2020PTC139065
139065
26 September 2020
₹1.50 M
₹1.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Subtle Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Menaka Thangaraj | Director | 26 Sep 2020 | Current |
| Ujjani Shivananjappa Sunil Kumar | Director | 26 Sep 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Subtle Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 85.61% increase. The company also saw a substantial improvement in profitability, with a 44.13% increase in profit. The company's net worth Soared by an impressive increase of 22.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Subtle Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,137,362.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2025 | State Bank Of India | ₹8.50 M | Open |
| 31 Mar 2023 | Hdfc Bank Limited | ₹0.32 M | Open |
| 31 Mar 2023 | Hdfc Bank Limited | ₹0.32 M | Open |
Explore comprehensive loan charge details -
Subtle Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Subtle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subtle Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with State Bank Of India amounted to Rs. 8.50 M with Charge ID 101051902 was registered on 13 Feb 2025. was recorded as a recent event.
Subtle Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Subtle Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.32 M with Charge ID 100753125 was registered on 31 Mar 2023. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.32 M with Charge ID 100753124 was registered on 31 Mar 2023. was recorded as a recent event.
Menaka Thangaraj was appointed as a Director was appointed as a Director on 26 Sep 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
The CIN of Subtle Pharmaceuticals Private Limited is U24304KA2020PTC139065.
Subtle Pharmaceuticals Private Limited is headquartered at 1St Floor, A 419 And A 420,, 9 And 10Th Main Road, 2Nd Stage, Peenya Industrial Area, Bangalore North, Karnataka, 560058.
Subtle Pharmaceuticals Private Limited was incorporated on 26 September 2020.
The current directors of Subtle Pharmaceuticals Private Limited are
The primary industry of Subtle Pharmaceuticals Private Limited is Manufacturing.
Subtle Pharmaceuticals Private Limited is unlisted.
The authorized capital of Subtle Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX